Related references
Note: Only part of the references are listed.Effects of different doses of ticagrelor on platelet aggregation and endothelial function in diabetic patients with stable coronary artery disease
Meijiao He et al.
PLATELETS (2019)
Complementary Role of P2 and Adenosine Receptors in ATP Induced-Anti-Apoptotic Effects Against Hypoxic Injury of HUVECs
Catherine Feliu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Ticagrelor Does Not Protect Isolated Rat Hearts, Thus Clouding Its Proposed Cardioprotective Role Through ENT 1 in Heart Tissue
Xi-Ming Yang et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS (2019)
Ability of CP-532,903 to protect mouse hearts from ischemia/reperfusion injury is dependent on expression of A3 adenosine receptors in cardiomyoyctes
Tina C. Wan et al.
BIOCHEMICAL PHARMACOLOGY (2019)
Ticagrelor and clopidogrel suppress NF-κB signaling pathway to alleviate LPS-induced dysfunction in vein endothelial cells
Zhuyin Jia et al.
BMC CARDIOVASCULAR DISORDERS (2019)
Impact of ticagrelor on P2Y1 and P2Y12 localization and on cholesterol levels in platelet plasma membrane
Vahideh Rabani et al.
PLATELETS (2018)
Ticagrelor, a P2Y12 antagonist, attenuates vascular dysfunction and inhibits atherogenesis in apolipoprotein-E-deficient mice
Byambasuren Ganbaatar et al.
ATHEROSCLEROSIS (2018)
Adenosine and Ticagrelor Plasma Levels in Patients With and Without Ticagrelor-Related Dyspnea
Luis Ortega-Paz et al.
CIRCULATION (2018)
P2Y12 antagonists and cardiac repair post-myocardial infarction: global and regional heart function analysis and molecular assessments in pigs
Gemma Vilahur et al.
CARDIOVASCULAR RESEARCH (2018)
Reorganization of platelet membrane sphingomyelins by adenosine diphosphate and ticagrelor
Fatemeh Haghighi et al.
CHEMISTRY AND PHYSICS OF LIPIDS (2018)
Accurate measurement of endogenous adenosine in human blood
Lars Lofgren et al.
PLOS ONE (2018)
Quantification of unbound concentration of ticagrelor in plasma as a proof of mechanism biomarker of the reversal agent, MEDI2452
Ann-Sofie Sandinge et al.
PLOS ONE (2018)
Compared efficacy of clopidogrel and ticagrelor in treating acute coronary syndrome: a meta-analysis
Dong Wang et al.
BMC CARDIOVASCULAR DISORDERS (2018)
THE ROLE OF PURINERGIC P2Y12 RECEPTOR BLOCKERS ON THE ANGIOGENIC PROPERTIES OF ENDOTHELIAL CELLS: AN IN VITRO STUDY
K. Korybalska et al.
JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY (2018)
Population Pharmacokinetic-Pharmacodynamic Modeling of Ropivacaine in Spinal Anesthesia
Zoubir Djerada et al.
CLINICAL PHARMACOKINETICS (2018)
Current knowledge on the role of P2Y receptors in cardioprotection against ischemia-reperfusion
Zoubir Dierada et al.
PHARMACOLOGICAL RESEARCH (2017)
Purinergic Signaling in the Cardiovascular System
Geoffrey Burnstock
CIRCULATION RESEARCH (2017)
Effects of P2Y12 receptor antagonists beyond platelet inhibition - comparison of ticagrelor with thienopyridines
Sven Nylander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2016)
Cangrelor-Mediated Cardioprotection Requires Platelets and Sphingosine Phosphorylation
Michael V. Cohen et al.
CARDIOVASCULAR DRUGS AND THERAPY (2016)
Protective Effects of Ticagrelor on Myocardial Injury After Infarction
Gemma Vilahur et al.
CIRCULATION (2016)
How does adenosine control neuronal dysfunction and neurodegeneration?
Rodrigo A. Cunha
JOURNAL OF NEUROCHEMISTRY (2016)
Cytoprotective pathways in the vascular endothelium. Do they represent a viable therapeutic target?
Justin C. Mason
VASCULAR PHARMACOLOGY (2016)
Activation of P2X7 and P2Y11 purinergic receptors inhibits migration and normalizes tumor-derived endothelial cells via cAMP signaling
D. Avanzato et al.
SCIENTIFIC REPORTS (2016)
Ticagrelor Protects the Heart Against Reperfusion Injury and Improves Remodeling After Myocardial Infarction
Yumei Ye et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2015)
Cardioprotective Properties of the Platelet P2Y12 Receptor Inhibitor, Cangrelor: Protective in Diabetics and Reliant Upon the Presence of Blood
R. M. Bell et al.
CARDIOVASCULAR DRUGS AND THERAPY (2015)
Validation of a fast UPLC-MS/MS method for quantitative analysis of opioids, cocaine, amphetamines (and their derivatives) in human whole blood
Catherine Feliu et al.
BIOANALYSIS (2015)
Chronic Treatment With Ticagrelor Limits Myocardial Infarct Size An Adenosine and Cyclooxygenase-2-Dependent Effect
Manjyot K. Nanhwan et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2014)
Population pharmacokinetics of nefopam in elderly, with or without renal impairment, and its link to treatment response
Zoubir Djerada et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2014)
Characterization of the Adenosine Pharmacology of Ticagrelor Reveals Therapeutically Relevant Inhibition of Equilibrative Nucleoside Transporter 1
Duncan Armstrong et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS (2014)
Strategies for quantitation of endogenous adenine nucleotides in human plasma using novel ion-pair hydrophilic interaction chromatography coupled with tandem mass spectrometry
Guodong Zhang et al.
JOURNAL OF CHROMATOGRAPHY A (2014)
Adenosine-Mediated Effects of Ticagrelor Evidence and Potential Clinical Relevance
Marco Cattaneo et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Ticagrelor Increases Adenosine Plasma Concentration in Patients With an Acute Coronary Syndrome
Laurent Bonello et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Ticagrelor: Pharmacokinetics, Pharmacodynamics, Clinical Efficacy, and Safety
Paul P. Dobesh et al.
PHARMACOTHERAPY (2014)
Endothelium and Its Alterations in Cardiovascular Diseases: Life Style Intervention
Gaia Favero et al.
BIOMED RESEARCH INTERNATIONAL (2014)
Purinergic Signaling and Blood Vessels in Health and Disease
Geoffrey Burnstock et al.
PHARMACOLOGICAL REVIEWS (2014)
Extracellular NAADP affords cardioprotection against ischemia and reperfusion injury and involves the P2Y11-like receptor
Zoubir Djerada et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)
Ticagrelor Improves Peripheral Arterial Function in Patients with a Previous Acute Coronary Syndrome
Kristina Torngren et al.
CARDIOLOGY (2013)
Two Classes of Anti-Platelet Drugs Reduce Anatomical Infarct Size in Monkey Hearts
Xi-Ming Yang et al.
CARDIOVASCULAR DRUGS AND THERAPY (2013)
Triple Therapy Greatly Increases Myocardial Salvage During Ischemia/Reperfusion in the in situ Rat Heart
Xi-Ming Yang et al.
CARDIOVASCULAR DRUGS AND THERAPY (2013)
Differential Effect of Ticagrelor Versus Prasugrel on Coronary Blood Flow Velocity in Patients With Non-ST-Elevation Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: An Exploratory Study
Dimitrios Alexopoulos et al.
CIRCULATION-CARDIOVASCULAR INTERVENTIONS (2013)
Platelet P2Y12 Blockers Confer Direct Postconditioning-Like Protection in Reperfused Rabbit Hearts
Xi-Ming Yang et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS (2013)
Validation of a fast method for quantitative analysis of elvitegravir, raltegravir, maraviroc, etravirine, tenofovir, boceprevir and 10 other antiretroviral agents in human plasma samples with a new UPLC-MS/MS technology
Zoubir Djerada et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2013)
Ticagrelor Enhances Adenosine-Induced Coronary Vasodilatory Responses in Humans
Ann Wittfeldt et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Ticagrelor inhibits human platelet aggregation via adenosine in addition to P2Y12 antagonism
S. Nylander et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2013)
The mechanism of beta-adrenergic preconditioning: roles for adenosine and ROS during triggering and mediation
Ruduwaan Salie et al.
BASIC RESEARCH IN CARDIOLOGY (2012)
Cardioprotection by clopidogrel in acute ST-elevated myocardial infarction patients: a retrospective analysis
Francois Roubille et al.
BASIC RESEARCH IN CARDIOLOGY (2012)
Extracellular ATP attenuates ischemia-induced caspase-3 cleavage in human endothelial cells
D. Urban et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2012)
Ticagrelor Inhibits Adenosine Uptake In Vitro and Enhances Adenosine-Mediated Hyperemia Responses in a Canine Model
J. J. J. van Giezen et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS (2012)
Anti-ischemic effects of multivalent dendrimeric A3 adenosine receptor agonists in cultured cardiomyocytes and in the isolated rat heart
Bella Chanyshev et al.
PHARMACOLOGICAL RESEARCH (2012)
Effect of A2A receptor antagonist (SCH 442416) on the mRNA expression of glutamate aspartate transporter and glutamine synthetase in rat retinal Muller cells under hypoxic conditions in vitro
Jun Yu et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2012)
Striatal Pre- and Postsynaptic Profile of Adenosine A2A Receptor Antagonists
Marco Orru et al.
PLOS ONE (2011)
Both A2a and A2b adenosine receptors at reperfusion are necessary to reduce infarct size in mouse hearts
Carmen Methner et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2010)
Adjunctive treatment with ticagrelor, but not clopidogrel, added to tPA enables sustained coronary artery recanalisation with recovery of myocardium perfusion in a canine coronary thrombosis model
Kai Wang et al.
THROMBOSIS AND HAEMOSTASIS (2010)
Quantitative Evaluation of Intracellular Metabolite Extraction Techniques for Yeast Metabolomics
Andre B. Canelas et al.
ANALYTICAL CHEMISTRY (2009)
Involvement of P2Y receptors in pyridoxal-5'-phosphate-induced cardiac preconditioning
Herve Millart et al.
FUNDAMENTAL & CLINICAL PHARMACOLOGY (2009)
The P2Y12 Antagonists, 2-Methylthioadenosine 5′-Monophosphate Triethylammonium Salt and Cangrelor (ARC69931MX), Can Inhibit Human Platelet Aggregation through a Gi-independent Increase in cAMP Levels
Subhashini Srinivasan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Simultaneous analysis of eight nucleoside triphosphates in cell lines by liquid chromatography coupled with tandem mass spectrometry
Sabine Cohen et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2009)
Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial
Gilles Montalescot et al.
LANCET (2009)
Adenosine A3 Receptor and Cardioprotection Enticing, Enigmatic, Elusive
Beverly A. Rothermel et al.
CIRCULATION (2008)
P2 purinoceptor-mediated cardioprotection in ischemic-reperfused mouse heart
Shirley Wee et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Adenosinergic cardioprotection: Multiple receptors, multiple pathways
Jason N. Peart et al.
PHARMACOLOGY & THERAPEUTICS (2007)
Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial
ZM Chen et al.
LANCET (2005)
A3 adenosine receptor-mediated protection of the ischemic heart
JP Headrick et al.
VASCULAR PHARMACOLOGY (2005)
Adenosine A3 receptor activation protects the myocardium from reperfusion/reoxygenation injury
HL Maddock et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2002)
Gene dosage-dependent effects of cardiac-specific overexpression of the A3 adenosine receptor
RG Black et al.
CIRCULATION RESEARCH (2002)
Endothelial damage during myocardial preservation and storage
A Parolari et al.
ANNALS OF THORACIC SURGERY (2002)
Role of endothelium in ischaemia-induced myocardial dysfunction of isolated working hearts:: cardioprotection by activation of adenosine A2A receptors
HL Maddock et al.
JOURNAL OF AUTONOMIC PHARMACOLOGY (2001)
Apoptosis of endothelial cells precedes myocyte cell apoptosis in ischemia/reperfusion injury
T Scarabelli et al.
CIRCULATION (2001)
Comparison of the potency of adenosine as an agonist at human adenosine receptors expressed in Chinese hamster ovary cells
BB Fredholm et al.
BIOCHEMICAL PHARMACOLOGY (2001)
Share Paper
